Entasis Therapeutics Holdings Inc.
ETTX
ETTX was delisted on the 8th of July, 2022.
27 hedge funds and large institutions have $12.5M invested in Entasis Therapeutics Holdings Inc. in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 5 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
117% more capital invested
Capital invested by funds: $5.77M → $12.5M (+$6.77M)
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
23% more funds holding
Funds holding: 22 → 27 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
+$2.5M |
| 2 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$2.26M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$751K |
| 4 |
DAM
Deltec Asset Management
New York
|
+$311K |
| 5 |
E
Ergoteles
New York
|
+$270K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.1M |
| 2 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$99K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$18.7K |
| 4 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
-$7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$5.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $2K | +$2K | +1,000 | New |
|
|
EAM
27
Eventide Asset Management
Boston,
Massachusetts
| – | -$1.1M | -590,602 | Closed |
|
|
28
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| – | -$99K | -52,797 | Closed |
|
|
SWM
29
Spire Wealth Management
Mclean,
Virginia
| – | -$7K | -4,000 | Closed |
|
|
FCA
30
FinTrust Capital Advisors
Greenville,
South Carolina
| – | -$1K | -654 | Closed |
|
ETTX Hedge Fund Activity: Q2 2022 in Review
27 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q2 2022, worth a combined $12.5M — up 117% from $5.77M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ETTX positions and 5 closed out — a net gain of 5 holders — while 7 added to existing stakes and 3 trimmed.
The largest buyer was Gardner Lewis Asset Management, opening a new position worth an estimated $2.5M. The largest seller was Eventide Asset Management, exiting entirely with an estimated $1.1M sold.
- 27 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q2 2022, up from 22 in Q1 2022.
- Funds reported $12.5M of Entasis Therapeutics Holdings Inc. stock for Q2 2022, up 117% quarter-over-quarter.
- 10 funds opened new Entasis Therapeutics Holdings Inc. positions in Q2 2022 and 5 closed out, a net change of +5 holders.
- The largest Entasis Therapeutics Holdings Inc. buyer in Q2 2022 was Gardner Lewis Asset Management, an estimated $2.5M added.
- The largest Entasis Therapeutics Holdings Inc. seller in Q2 2022 was Eventide Asset Management, an estimated $1.1M sold.
Based on aggregated 13F filings for Q2 2022.